JP2022065024A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022065024A5 JP2022065024A5 JP2022017196A JP2022017196A JP2022065024A5 JP 2022065024 A5 JP2022065024 A5 JP 2022065024A5 JP 2022017196 A JP2022017196 A JP 2022017196A JP 2022017196 A JP2022017196 A JP 2022017196A JP 2022065024 A5 JP2022065024 A5 JP 2022065024A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- dry eye
- eye
- trifluoromethylchroman
- iriden
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022171542A JP7801201B2 (ja) | 2019-10-04 | 2022-10-26 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2026000075A JP2026042857A (ja) | 2019-10-04 | 2026-01-05 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019184053 | 2019-10-04 | ||
| JP2019184053 | 2019-10-04 | ||
| PCT/JP2020/037548 WO2021066144A1 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2021541679A JP7025094B2 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541679A Division JP7025094B2 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022171542A Division JP7801201B2 (ja) | 2019-10-04 | 2022-10-26 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022065024A JP2022065024A (ja) | 2022-04-26 |
| JP2022065024A5 true JP2022065024A5 (https=) | 2022-05-10 |
| JP7248836B2 JP7248836B2 (ja) | 2023-03-29 |
Family
ID=75338162
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541679A Active JP7025094B2 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2022017196A Active JP7248836B2 (ja) | 2019-10-04 | 2022-02-07 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2022171542A Active JP7801201B2 (ja) | 2019-10-04 | 2022-10-26 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2026000075A Pending JP2026042857A (ja) | 2019-10-04 | 2026-01-05 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541679A Active JP7025094B2 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022171542A Active JP7801201B2 (ja) | 2019-10-04 | 2022-10-26 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
| JP2026000075A Pending JP2026042857A (ja) | 2019-10-04 | 2026-01-05 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12533337B2 (https=) |
| EP (2) | EP4545095A3 (https=) |
| JP (4) | JP7025094B2 (https=) |
| KR (1) | KR20220078604A (https=) |
| CN (1) | CN114585357A (https=) |
| AU (1) | AU2026202464A1 (https=) |
| BR (1) | BR112022005992A2 (https=) |
| CA (1) | CA3156484A1 (https=) |
| DK (1) | DK4043014T3 (https=) |
| ES (1) | ES3031607T3 (https=) |
| HU (1) | HUE072085T2 (https=) |
| MX (2) | MX2022004027A (https=) |
| MY (1) | MY207759A (https=) |
| PH (1) | PH12022550805A1 (https=) |
| PL (1) | PL4043014T3 (https=) |
| PT (1) | PT4043014T (https=) |
| WO (1) | WO2021066144A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3156484A1 (en) | 2019-10-04 | 2021-04-08 | Senju Pharmaceutical Co., Ltd. | PHARMACEUTICAL MEDICINAL PRODUCT CONTAINING A HETEROCYCLIDENE ACETAMIDE DERIVATIVE |
| CN117120048A (zh) | 2021-03-30 | 2023-11-24 | 千寿制药株式会社 | 含杂环亚基乙酰胺衍生物的悬浮液 |
| KR20250065723A (ko) | 2022-09-29 | 2025-05-13 | 센주 세이야꾸 가부시키가이샤 | 멸균 처리한 헤테로시클리덴아세트아미드 유도체 함유 현탁액 |
| JP7589394B2 (ja) * | 2022-09-29 | 2024-11-25 | 千寿製薬株式会社 | ヘテロシクリデンアセトアミド誘導体を含む配合剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5621566A (en) | 1979-08-01 | 1981-02-28 | Alpha- Shokuhin Kk | Preparation of bifun from homegrown rice and apparatus used for it |
| CN101228131B (zh) * | 2005-07-22 | 2013-01-09 | 持田制药株式会社 | 新的杂环亚基乙酰胺衍生物 |
| JP4754566B2 (ja) | 2005-07-22 | 2011-08-24 | 持田製薬株式会社 | 新規なヘテロシクリデンアセトアミド誘導体 |
| RU2451014C2 (ru) | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| TW200927192A (en) | 2007-11-19 | 2009-07-01 | Alcon Res Ltd | Use of TRPV1 receptor antagonists for treating dry eye and ocular pain |
| US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
| EP2377850A1 (en) | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1 vanilloid receptor antagonists with a bicyclic portion |
| WO2012045729A1 (en) * | 2010-10-05 | 2012-04-12 | Glaxo Group Limited | Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists |
| GB201215857D0 (en) * | 2012-09-05 | 2012-10-24 | Sylentis Sau | siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| JP6230743B1 (ja) * | 2017-05-31 | 2017-11-15 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の結晶 |
| JP7373909B2 (ja) | 2018-04-06 | 2023-11-06 | 株式会社シマノ | 変速制御装置および変速システム |
| CA3156484A1 (en) | 2019-10-04 | 2021-04-08 | Senju Pharmaceutical Co., Ltd. | PHARMACEUTICAL MEDICINAL PRODUCT CONTAINING A HETEROCYCLIDENE ACETAMIDE DERIVATIVE |
-
2020
- 2020-10-02 CA CA3156484A patent/CA3156484A1/en active Pending
- 2020-10-02 PH PH1/2022/550805A patent/PH12022550805A1/en unknown
- 2020-10-02 CN CN202080069192.5A patent/CN114585357A/zh active Pending
- 2020-10-02 MY MYPI2022001736A patent/MY207759A/en unknown
- 2020-10-02 JP JP2021541679A patent/JP7025094B2/ja active Active
- 2020-10-02 KR KR1020227012080A patent/KR20220078604A/ko active Pending
- 2020-10-02 PL PL20872061.5T patent/PL4043014T3/pl unknown
- 2020-10-02 PT PT208720615T patent/PT4043014T/pt unknown
- 2020-10-02 WO PCT/JP2020/037548 patent/WO2021066144A1/ja not_active Ceased
- 2020-10-02 EP EP25164201.3A patent/EP4545095A3/en active Pending
- 2020-10-02 DK DK20872061.5T patent/DK4043014T3/da active
- 2020-10-02 EP EP20872061.5A patent/EP4043014B1/en active Active
- 2020-10-02 MX MX2022004027A patent/MX2022004027A/es unknown
- 2020-10-02 HU HUE20872061A patent/HUE072085T2/hu unknown
- 2020-10-02 BR BR112022005992A patent/BR112022005992A2/pt unknown
- 2020-10-02 ES ES20872061T patent/ES3031607T3/es active Active
- 2020-10-02 US US17/766,090 patent/US12533337B2/en active Active
-
2022
- 2022-02-07 JP JP2022017196A patent/JP7248836B2/ja active Active
- 2022-04-01 MX MX2025005474A patent/MX2025005474A/es unknown
- 2022-10-26 JP JP2022171542A patent/JP7801201B2/ja active Active
-
2025
- 2025-01-03 US US19/009,260 patent/US12502375B2/en active Active
-
2026
- 2026-01-05 JP JP2026000075A patent/JP2026042857A/ja active Pending
- 2026-03-31 AU AU2026202464A patent/AU2026202464A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022065024A5 (https=) | ||
| JP2023011735A5 (https=) | ||
| JP2018513107A5 (https=) | ||
| JP2017528507A5 (https=) | ||
| US20180000816A1 (en) | Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions | |
| JP2012520249A5 (https=) | ||
| JP2020512364A (ja) | 筋ジストロフィーの処置方法において使用するためのニンテダニブ | |
| JP2021515758A5 (https=) | ||
| JP2017528503A5 (https=) | ||
| JP2023098936A5 (https=) | ||
| AU2010304755A1 (en) | Use of rasagiline for the treatment of Progressive Supranuclear Palsy | |
| JP2014525426A5 (https=) | ||
| JP2009526021A5 (https=) | ||
| JP2013500977A5 (https=) | ||
| JP2017522300A5 (https=) | ||
| JP2009544665A5 (https=) | ||
| RU2017116974A (ru) | Офтальмологическая композиция, содержащая циклоспорин и трегалозу | |
| Urakov et al. | COVID-19: What drug can be used to treat a new coronavirus disease and why | |
| JP2019502719A5 (https=) | ||
| JP2025517509A (ja) | 脊髄小脳失調症を治療する方法 | |
| JPWO2019166631A5 (https=) | ||
| JP2020007333A5 (https=) | ||
| MX2023002156A (es) | Acido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentan o-1-carboxilico y derivados del mismo para su uso en el tratamiento de enfermedades de las vias respiratorias. | |
| RU2016105158A (ru) | Соединения мочевины и их применение в качестве ингибиторов гидролазы амидов жирных кислот | |
| JPWO2023163203A5 (https=) |